arginyl-glycyl-aspartic acid and Alveolitis, Fibrosing

arginyl-glycyl-aspartic acid has been researched along with Alveolitis, Fibrosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barksby, BS; Barnes, R; Barrett, JW; Barrett, TN; Borthwick, LA; Burgoyne, RA; Fisher, AJ; Gower, E; Hatley, RJD; Jenkins, RG; John, AE; Luckett, JC; Macdonald, SJF; Man, Y; Marshall, RP; Morrison, VS; Procopiou, PA; Pun, KT; Roper, JA; Slack, RJ; Wilkinson, AL	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Alveolitis, Fibrosing

Article	Year
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease. European journal of pharmacology, 2021, Dec-15, Volume: 913 Topics: Administration, Oral; Animals; Antifibrotic Agents; Antigens, Neoplasm; Biological Availability; Bleomycin; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Humans; Integrins; Lung; Lysosomes; Male; Mice; Oligopeptides; Primary Cell Culture; Proteolysis; Pulmonary Fibrosis; Transforming Growth Factor beta	2021

Article

Year

Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.

European journal of pharmacology, 2021, Dec-15, Volume: 913

Topics: Administration, Oral; Animals; Antifibrotic Agents; Antigens, Neoplasm; Biological Availability; Bleomycin; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Humans; Integrins; Lung; Lysosomes; Male; Mice; Oligopeptides; Primary Cell Culture; Proteolysis; Pulmonary Fibrosis; Transforming Growth Factor beta

2021